Table 2 |
|||
|
Presenting symptoms and signs of SAE cases reported to have occurred following ivermectin mass treatment from 1989 to 2001* |
|||
| Nature of Symptoms |
Frequency of occurrence† (%) |
Nature of Signs |
Frequency of occurrence† (%) |
|
|
|||
| Difficulty or inability to stand or walk |
60 (29.0) |
Altered Mental Status |
106 (51.2) |
| Feverishness |
54 (26.1) |
Fever (documented) |
51 (24.6) |
| Headache |
52 (25.1) |
Incontinence (urinary and/or fecal) |
42 (20.3) |
| General myalgia or arthralgia |
51 (24.6) |
Dysarthria |
26 (12.6) |
| Fatigue/Asthenia |
40 (19.3) |
Subconjunctival hemorrhage |
26 (12.6) |
| Diarrhea |
33 (15.9) |
Rash and/or urticuria |
23 (11.1) |
| Vertigo |
31 (15.0) |
Generalized edema |
16 (7.7) |
| Dyspnea |
22 (10.6) |
Extremity edema |
16 (7.7) |
| Pruritis |
20 (9.7) |
Facial edema |
15 (7.3) |
| Nausea or vomiting |
19 (9.1) |
Hypotension (documented) |
13 (6.3) |
|
|
|||
|
*cases reported as of August 31, 2002; †total of individual percentages is greater than 100 because most patients presented with multiple symptoms and signs. |
|||
|
Twum-Danso Filaria Journal 2003 2(Suppl 1):S3 doi:10.1186/1475-2883-2-S1-S3 |
|||
